Cyclopharm Ltd
ASX:CYC
CYC's latest stock split occurred on May 28, 2012
The company executed a 1-for-5 stock split, meaning that for every 5 shares held, investors received 1 new share.
The adjusted shares began trading on May 28, 2012. This was CYC's 2nd stock split, following the previous one in Oct 20, 2008.
1S9
Cyclopharm Ltd
Glance View
Cyclopharm Ltd. is a radiopharmaceutical company, which engages in the diagnostic imaging in lung health. The company provides diagnostic imaging services specializing in lung health. The firm through its medical device and pharmaceutical products under the name of Technegas, which has become the industry in diagnostic functional lung imaging technology. The company distributes its products in approximately 60 countries throughout the world with over 1500 nuclear medicine departments utilizing Technegas. The firm formed a joint venture with Alfred Health Solutions and Macquarie University Hospital to provide various imaging services on-site at the hospital. The Macquarie Medical Imaging (MMI) offers a range of diagnostic radiology, interventional radiology, nuclear medicine and molecular imaging services for inpatient and outpatients. Its Ultralute is a device that extends the useful life of Molybdenum-99 (Mo-99) generators.
You don't have any saved screeners yet